Amrita Prayag

528 total citations
21 papers, 289 citations indexed

About

Amrita Prayag is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Amrita Prayag has authored 21 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Epidemiology and 4 papers in Molecular Medicine. Recurrent topics in Amrita Prayag's work include Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Amrita Prayag is often cited by papers focused on Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Amrita Prayag collaborates with scholars based in India and United States. Amrita Prayag's co-authors include Ella Ariza‐Heredia, Roy F. Chemaly, Shashank S. Ghantoji, Samuel L Aitken, Ashakumary Lakshmikuttyamma, Farnaz Foolad, Sunday Shoyele, Thanh Nguyen, Asha Srinivasan and Terri Lynn Shigle and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Journal of Cellular Physiology.

In The Last Decade

Amrita Prayag

19 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amrita Prayag India 7 135 105 52 41 34 21 289
Mi-Ran Seo South Korea 11 167 1.2× 119 1.1× 123 2.4× 59 1.4× 25 0.7× 23 355
A Ondrusova Slovakia 8 100 0.7× 94 0.9× 68 1.3× 16 0.4× 25 0.7× 16 308
Minje Han South Korea 12 91 0.7× 102 1.0× 62 1.2× 19 0.5× 26 0.8× 27 320
Bindu Dey India 8 110 0.8× 41 0.4× 72 1.4× 65 1.6× 53 1.6× 11 255
Nicholas Farinola Australia 9 77 0.6× 81 0.8× 90 1.7× 44 1.1× 19 0.6× 15 351
Mao Mao An China 12 101 0.7× 148 1.4× 77 1.5× 13 0.3× 11 0.3× 14 354
Chia Sui Ong Malaysia 8 127 0.9× 73 0.7× 109 2.1× 13 0.3× 9 0.3× 24 297
Sunil Kumar Dhatwalia India 12 121 0.9× 153 1.5× 66 1.3× 13 0.3× 79 2.3× 22 301
Khanit Sa‐ngiamsuntorn Thailand 11 60 0.4× 43 0.4× 109 2.1× 19 0.5× 39 1.1× 29 421

Countries citing papers authored by Amrita Prayag

Since Specialization
Citations

This map shows the geographic impact of Amrita Prayag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amrita Prayag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amrita Prayag more than expected).

Fields of papers citing papers by Amrita Prayag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amrita Prayag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amrita Prayag. The network helps show where Amrita Prayag may publish in the future.

Co-authorship network of co-authors of Amrita Prayag

This figure shows the co-authorship network connecting the top 25 collaborators of Amrita Prayag. A scholar is included among the top collaborators of Amrita Prayag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amrita Prayag. Amrita Prayag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rajhans, Prasad, et al.. (2025). Bacteremia Caused by Rare NFGNB in the ICU: A Single-center Experience. Indian Journal of Critical Care Medicine. 29(4). 345–351.
2.
Soman, Rajeev, et al.. (2024). Candida auris – Comparison of sensititre YeastOne and Vitek 2 AST systems for antifungal susceptibility testing – A single centre experience. Indian Journal of Medical Microbiology. 50. 100618–100618. 4 indexed citations
3.
4.
5.
Soman, Rajeev, et al.. (2023). Ceftazidime-avibactam with or without Aztreonam vs Polymyxin-based Combination Therapy for Carbapenem-resistant Enterobacteriaceae: A Retrospective Analysis. Indian Journal of Critical Care Medicine. 27(6). 444–450. 8 indexed citations
6.
Saseedharan, Sanjith, et al.. (2023). Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India. Indian Journal of Critical Care Medicine. 27(4). 260–264. 4 indexed citations
7.
8.
Prayag, Amrita, et al.. (2022). The Dominance of Candida auris: A Single-center Experience of 79 Episodes of Candidemia from Western India. Indian Journal of Critical Care Medicine. 26(5). 560–563. 17 indexed citations
9.
Mahalle, Namita, et al.. (2022). Factors associated with subtherapeutic levels of oral posaconazole tablet: a detailed analysis from a tertiary care center in India. International Journal of Infectious Diseases. 124. 76–80. 3 indexed citations
10.
Prayag, Amrita, et al.. (2022). COVID-19 Associated Vertebral Osteomyelitis Caused by Aspergillus Species—A Case Series. Indian Journal of Orthopaedics. 56(7). 1268–1276. 3 indexed citations
11.
Rajhans, Prasad, et al.. (2020). A Retrospective Observational Study of Hypoxic COVID-19 Patients Treated with Immunomodulatory Drugs in a Tertiary Care Hospital. Indian Journal of Critical Care Medicine. 24(11). 1020–1027. 13 indexed citations
12.
Kulkarni, Prathit A., Marjorie Vieira Batista, Firas El Chaer, et al.. (2019). Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006–2014. BMC Infectious Diseases. 19(1). 934–934. 11 indexed citations
13.
Prayag, Amrita. (2019). Overview and Principles of Scientific Writing. Indian Journal of Medical and Paediatric Oncology. 40(3). 420–423. 2 indexed citations
14.
Prayag, Amrita. (2019). Challenges in Scientific Writing. Indian Journal of Medical and Paediatric Oncology. 40(4). 554–555. 2 indexed citations
15.
Prayag, Amrita, et al.. (2018). Synergistic anticancer action of quercetin and curcumin against triple‐negative breast cancer cell lines. Journal of Cellular Physiology. 234(7). 11103–11118. 94 indexed citations
16.
Foolad, Farnaz, Samuel L Aitken, Terri Lynn Shigle, et al.. (2018). Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Clinical Infectious Diseases. 68(10). 1641–1649. 64 indexed citations
17.
Haddad, Lynn El, Ella Ariza‐Heredia, Dimpy P. Shah, et al.. (2018). The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. The Journal of Infectious Diseases. 219(6). 898–907. 46 indexed citations
18.
Aitken, Samuel L, Firas El Chaer, Amrita Prayag, et al.. (2018). Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant. Biology of Blood and Marrow Transplantation. 24(3). S385–S386.
19.
Aitken, Samuel L, Marjorie Vieira Batista, Firas El Chaer, et al.. (2018). 1561. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant. Open Forum Infectious Diseases. 5(suppl_1). S486–S486. 3 indexed citations
20.
Foolad, Farnaz, Amrita Prayag, Shashank S. Ghantoji, Ella Ariza‐Heredia, & Roy F. Chemaly. (2017). Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients. Biology of Blood and Marrow Transplantation. 23(3). S189–S189. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mi-Ran Seo Breakdown of academic impact, for papers by A Ondrusova Breakdown of academic impact, for papers by Minje Han Breakdown of academic impact, for papers by Bindu Dey Breakdown of academic impact, for papers by Nicholas Farinola Breakdown of academic impact, for papers by Mao Mao An Breakdown of academic impact, for papers by Chia Sui Ong Breakdown of academic impact, for papers by Sunil Kumar Dhatwalia Breakdown of academic impact, for papers by Khanit Sa‐ngiamsuntorn
Rankless by CCL
2026